Please provide your email address to receive an email when new articles are posted on . In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic reactions in ...
Please provide your email address to receive an email when new articles are posted on . Healio compiled the most-read news in allergy, asthma and immunology posted in October. These reports included ...
Using household cleaning sprays and air fresheners as little as once a week can raise the risk of developing asthma in adults, say researchers in Europe. Such products have been associated with ...
Tiotropium Respimat is an inhaled corticosteroid drug patients administer once daily through Boehringer Ingelheim’s Respimat inhaler. The FDA first approved the drug in 2015 for asthma patients age 12 ...
A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results